Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors

Part of paid clinical trials in Salt Lake City, Utah.

Sponsor
University of Utah
Study ID
NCT07120100
Status
Recruiting
Apply to this trial

Conditions

  • Breast Cancer Female
  • Gynecologic Cancer

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • rTMS — DEVICE
    Repetitive Transcranial Magnetic Stimulation will be administered Monday-Friday for two weeks (10 sessions total)

Study Details

The goal of this study is to evaluate the change in pain scores among patients with chemotherapy-induced peripheral neuropathy after receiving treatment with repetitive transcranial magnetic stimulation (rTMS).

Key Dates

Start date
Aug 27, 2025
Status verified
May 2026
Primary completion
Sep 15, 2027
Completion
Sep 15, 2028

Study Design

Enrollment
19 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Repetitive Transcranial Magnetic Stimulation (rTMS) Administration

Primary Outcome Measure

Change in Pain Numeric Rating Scale (PNRS) between screening and end of treatment in subjects who complete at least 7 rTMS treatments. [ Time Frame: 5 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Huntsman Cancer Institute at University of UtahSalt Lake CityUtah84112
Janna Espinosa
[email protected]
801-585-0571
Newaj Abdullah, MD
[email protected]
801-585-0255

Find similar trials in Salt Lake City, UT

By research site
Huntsman Cancer Institute at University of Utah· Salt Lake City, UT

Related Studies